Stay updated with breaking news from Bxrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Baudax Bio (NASDAQ:BXRX – Get Free Report) is scheduled to post its quarterly earnings results on Wednesday, February 21st. Baudax Bio (NASDAQ:BXRX – Get Free Report) last announced its quarterly earnings results on Monday, November 20th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.53) by $0.24. On average, analysts […]
Baudax Bio (NASDAQ:BXRX – Get Free Report) issued its earnings results on Monday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.24, reports. Baudax Bio Stock Down 10.0 % Baudax Bio stock traded down $0.01 during mid-day trading on Thursday, hitting $0.06. 344,225 shares of the company were […]
By Chris Wack Baudax Bio shares doubled to 67 cents after the company said that U.S. Food and Drug Administration has granted orphan drug designation to its...
Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the recipient of a significant drop in short interest in August. As of August 15th, there was short interest totalling 142,700 shares, a drop of 27.8% from the July 31st total of 197,700 shares. Approximately 1.7% of the company’s shares are short sold. Based on an […]
Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 142,700 shares, a decrease of 27.8% from the July 31st total of 197,700 shares. Currently, 1.7% of the shares of the stock are […]